PL1720853T3 - Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania - Google Patents

Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania

Info

Publication number
PL1720853T3
PL1720853T3 PL04806748T PL04806748T PL1720853T3 PL 1720853 T3 PL1720853 T3 PL 1720853T3 PL 04806748 T PL04806748 T PL 04806748T PL 04806748 T PL04806748 T PL 04806748T PL 1720853 T3 PL1720853 T3 PL 1720853T3
Authority
PL
Poland
Prior art keywords
preparation
polymorphic form
imatinib mesylate
novel polymorphic
novel
Prior art date
Application number
PL04806748T
Other languages
English (en)
Inventor
Kompella Amala
Rao Thungathurthi Srinivasa
Kali Satya Bhujanga Rao Adibhatla
Sreenivas Rachakonda
Chowdary Nannapaneni Venkaiah
Khadgapathi Podili
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34856856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1720853(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Publication of PL1720853T3 publication Critical patent/PL1720853T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL04806748T 2004-02-11 2004-11-16 Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania PL1720853T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN105CH2004 2004-02-11
EP04806748.2A EP1720853B2 (en) 2004-02-11 2004-11-16 Pharmaceutical compositions of the 2 crystalline form of imatinib mesylate for use in the treatment of chronic myelogenous leukemia
PCT/IN2004/000352 WO2005077933A1 (en) 2004-02-11 2004-11-16 Novel polymorphic form of imatinib mesylate and a process for its preparation

Publications (1)

Publication Number Publication Date
PL1720853T3 true PL1720853T3 (pl) 2016-06-30

Family

ID=34856856

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04806748T PL1720853T3 (pl) 2004-02-11 2004-11-16 Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania

Country Status (10)

Country Link
US (1) US8048883B2 (pl)
EP (1) EP1720853B2 (pl)
CA (1) CA2555804C (pl)
DK (1) DK1720853T3 (pl)
ES (1) ES2565078T3 (pl)
HU (1) HUE028884T2 (pl)
PL (1) PL1720853T3 (pl)
PT (1) PT1720853E (pl)
SI (1) SI1720853T1 (pl)
WO (1) WO2005077933A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
PL1720853T3 (pl) 2004-02-11 2016-06-30 Natco Pharma Ltd Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania
TR200701870T1 (tr) 2004-09-02 2007-05-21 Cipla Limited İmatinib mesilatın kararlı kristal formu ve bu formun hazırlanması için işlem.
WO2006048890A1 (en) * 2004-11-04 2006-05-11 Sun Pharmaceutical Industries Limited Imatinib mesylate crystal form and process for preparation thereof
WO2006054314A1 (en) * 2004-11-17 2006-05-26 Natco Pharma Limited Polymorphic forms of imatinib mesylate
JP2009506014A (ja) * 2005-08-26 2009-02-12 ノバルティス アクチエンゲゼルシャフト イマチニブメシレートのデルタおよびイプシロン結晶形
AU2006316823A1 (en) 2005-11-25 2007-05-31 Novartis Ag F,G,H,I and K crystal forms of imatinib mesylate
US7977348B2 (en) 2006-04-27 2011-07-12 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
WO2007136510A2 (en) * 2006-04-27 2007-11-29 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
US8067421B2 (en) 2006-04-27 2011-11-29 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
EP1988089A1 (en) 2006-10-26 2008-11-05 Sicor, Inc. Imatinib base, and imatinib mesylate and processes for preparation thereof
MX2010003200A (es) * 2007-09-25 2010-04-30 Teva Pharma Composiciones de imatibnib estables.
US7947699B2 (en) 2008-01-10 2011-05-24 Actavis Group Ptc Ehf Anhydrous amorphous imatinib mesylate
US20100330130A1 (en) 2009-05-22 2010-12-30 Actavis Group Ptc Ehf Substantially pure imatinib or a pharmaceutically acceptable salt thereof
CZ2009570A3 (cs) 2009-08-26 2011-03-09 Zentiva, K. S. Príprava, stabilizace a využití polymorfu imatinib mesylátu pro vývoj lékových forem
WO2011095835A1 (en) 2010-02-02 2011-08-11 Actavis Group Ptc Ehf Highly pure imatinib or a pharmaceutically acceptable salt thereof
EP2536707A1 (en) 2010-02-15 2012-12-26 Reliance Life Sciences Pvt., Ltd. Process for the preparation of alpha form of imatinib mesylate
PL390611A1 (pl) 2010-03-04 2011-09-12 Tomasz Koźluk Sposób otrzymywania polimorficznej formy alfa i nowa forma polimorficzna mesylanu imatinibu
CA2792472A1 (en) * 2010-03-15 2011-09-22 Natco Pharma Limited Process for the preparation of highly pure crystalline imatinib base
EA024088B1 (ru) * 2010-06-18 2016-08-31 КРКА, д.д., НОВО МЕСТО α-ФОРМА МЕЗИЛАТА ИМАТИНИБА, СПОСОБЫ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЁ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
CN102477031B (zh) 2010-11-30 2015-07-15 浙江九洲药业股份有限公司 一种甲磺酸伊马替尼α晶型的制备方法
WO2012090221A1 (en) 2010-12-29 2012-07-05 Cadila Healthcare Limited Novel salts of imatinib
PL394169A1 (pl) 2011-03-09 2012-09-10 Adamed Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna metanosulfonianu imatinibu do napełniania jednostkowych postaci dawkowania oraz sposób jej wytwarzania
JP2014509642A (ja) 2011-03-31 2014-04-21 アイエヌディー−スイフト ラボラトリーズ リミテッド イマチニブ及びそのメシル酸塩の生成のための改良方法
EP2604596A1 (en) * 2011-12-16 2013-06-19 Deva Holding Anonim Sirketi Polymorphs of imatinib
CN102584787B (zh) * 2012-01-19 2015-01-07 山东金城医药化工股份有限公司 甲磺酸伊马替尼晶体的超声制备方法
AU2013223749A1 (en) 2012-02-21 2014-09-11 Sun Pharmaceutical Industries Limited Stable dosage forms of imatinib mesylate
IN2012DE00728A (pl) 2012-03-13 2015-08-21 Fresenius Kabi Oncology Ltd
CA2877030A1 (en) 2012-06-22 2013-12-27 Basf Se Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
KR101242955B1 (ko) * 2012-06-25 2013-03-12 제일약품주식회사 이마티닙 메실레이트 결정형 α의 제조 방법
US9439903B2 (en) 2012-10-25 2016-09-13 Cadila Healthcare Limited Process for the preparation of amorphous imatinib mesylate
EP3007699A4 (en) * 2013-06-12 2017-01-18 Shilpa Medicare Limited Crystalline imatinib mesylate process
EA029062B9 (ru) * 2013-09-20 2018-05-31 Тютор С.А.С.И.Ф.И.А. Способ получения фармацевтической композиции и продукт способа
WO2015188243A1 (en) * 2014-06-10 2015-12-17 Cristália Produtos Químicos Farmacêuticos Ltda PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
WO2017078647A1 (en) 2015-11-05 2017-05-11 Koçak Farma Ilaç Ve Kimya Sanayi Anonim Şirketi Pharmaceutical compositions of imatinib
WO2017129624A1 (en) 2016-01-25 2017-08-03 Krka, D.D., Novo Mesto Fast dispersible pharmaceutical composition comprising tyrosine-kinase inhibitor
AR111469A1 (es) 2017-04-21 2019-07-17 Yuhan Corp Sal de un compuesto del derivado de aminopiridina, una forma cristalina de la misma, y un proceso para preparar la misma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (pl) * 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
ITMI992711A1 (it) † 1999-12-27 2001-06-27 Novartis Ag Composti organici
GB0209265D0 (en) † 2002-04-23 2002-06-05 Novartis Ag Organic compounds
GB2398565A (en) * 2003-02-18 2004-08-25 Cipla Ltd Imatinib preparation and salts
WO2004106326A1 (en) * 2003-06-02 2004-12-09 Hetero Drugs Limited Novel polymorphs of imatinib mesylate
PL1720853T3 (pl) † 2004-02-11 2016-06-30 Natco Pharma Ltd Nowa odmiana polimorficzna metanosulfonianu imatynibu i sposób jej otrzymywania

Also Published As

Publication number Publication date
ES2565078T3 (es) 2016-03-31
PT1720853E (pt) 2016-03-04
EP1720853A1 (en) 2006-11-15
CA2555804A1 (en) 2005-08-25
SI1720853T1 (sl) 2016-04-29
CA2555804C (en) 2012-06-26
WO2005077933A1 (en) 2005-08-25
EP1720853B1 (en) 2015-12-30
EP1720853B2 (en) 2023-06-28
US8048883B2 (en) 2011-11-01
US20080255138A1 (en) 2008-10-16
DK1720853T3 (en) 2016-03-29
HUE028884T2 (en) 2017-01-30

Similar Documents

Publication Publication Date Title
SI1720853T1 (sl) Nova polimorfna oblika imatinibijevega mesilata in postopek za njeno pripravo
AU2003237596A1 (en) Novel polymorphs of imatinib mesylate
IL180859A0 (en) Imatinib mesylate alpha form and production process therefor
IL180861A0 (en) Crystalline imatinib base and production process therefor
IL183185A0 (en) Process of making crystalline aripiprazole
EP2176241A4 (en) NOVEL ERLOTINIB-FREE BASED MOISTURIZED FORM AND PROCESS FOR PREPARING THE ERLOTINIB HYDROCHLORIC HYDROCHL FORM A SUBSTANTIALLY FREE OF POLYMORPH FORM B
PL1802573T3 (pl) Proces syntezy 4-(3-metanosulfonylofenylo)-1-N-propylopiperydyny
PT2170844T (pt) Novos polimorfos de cloridrato de erlotinib e método de preparação
WO2007136510A3 (en) Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
PL1740593T3 (pl) Sposoby wytwarzania wodorosiarczanu klopidogrelu w formie polimorficznej I
IL191411A0 (en) Process for preparing pyridinamines and novel polymorphs thereof
IL192360A0 (en) Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
IL197954A0 (en) Process for the preparation of imatinib and intermediates thereof
IL163820A0 (en) Crystalline polymorphic form of irinotecan hydrochloride
HUP0700604A3 (en) Novel processes for preparation of a 2h-chromene
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
IL172004A0 (en) Polymorphic forms of ziprasidone hci and processes for their preparation
IL175514A0 (en) Polymorphic form b2 of ziprasidone base
EP1773339A4 (en) CRYSTALLINE FORM OF DONEPEZIL HYDROCHLORIDE
IL174213A0 (en) A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
IL170350A (en) Method for preparing polymorphism of irinotecan hydrochloride
IL175695A0 (en) Process for the preparation of valacyclovir hydrochloride
ZA200703495B (en) Process for the preparation of irbesartan hydrochloride
IL180498A0 (en) Process for production of steroids
IL182134A0 (en) Process for production of 2-chloro-4-nitroimidazole